| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2000;18:321-327
© 2000 Elsevier Science NL
a Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany
b Institute for Immunology, University of Heidelberg, Heidelberg, Germany
Received 7 December 1999; received in revised form 23 June 2000; accepted 28 June 2000.
Corresponding author. Tel.: +49-511-532-6584; fax: +49-511-532-5404
e-mail: klima{at}thg-mh.hannover.de
Objective: Myocardial injury from ischemia can be augmented after reperfusion due to proinflammatory events including complement activation, leukocyte adhesion, and release of various chemical mediators. It has been shown that intracoronary administration of a C1 esterase inhibitor (C1 INH) significantly reduces myocardial necrosis in an experimental model of ischemia. Our study addresses the question whether the most susceptible region of the heart for ischemic injury, the right ventricle (RV), can benefit from the protective effects of C1 esterase inhibition after transplantation. Methods: To precisely control RV volume in vivo an isovolumic model was used in which the RV volume was regulated using an intracavity high compliance balloon inserted into donor hearts of domestic pigs (34±4 kg). After 4 h of ischemia, donor hearts were transplanted into recipient pigs (44±4 kg). Treatment groups, each with six animals, consisted of C1 INH treatment or control. After opening the cross clamp, the C1 INH group animals received 20 IU/kg body weight of C1 INH intracoronary over a 5 min period. The control animals received no drug therapy. The hearts were reperfused for 60 min, and thereafter the RV balloon volume was increased in 10 ml increments until RV failure occurred. These measurements were repeated after 120 min of reperfusion. Results: There was no significant difference in maximal RV developed pressure between the two groups (after 1 h, 35.7±5.9 vs. 40.6±12.7 mmHg; after 2 h, 41.5±10.7 vs. 46.3±15.2 mmHg; for C1 INH and control animals, respectively). However, the RV could be loaded with a significantly higher volume after both 1 h (60.0±20.0 ml (C1 INH) vs. 46.7±13.7 ml (control) balloon volume, P<0.05), and 2 h of reperfusion (70.0±8.9 ml vs. 60.0±6.3 ml; C1 INH and control animals, respectively; P<0.05). Conclusions: Intracoronary administration of a C1 INH significantly improves right ventricular function in an experimental transplant model. Thus, inhibition of the classic complement cascade may be a promising therapeutic approach for effective protection of myocardium from reperfusion injury after transplantation.
Key Words: Myocardial protection • Heart transplantation • Right ventricular function • C1 esterase inhibitor
This article has been cited by other articles:
|
|
 |
|
  K. Baig, R. Nassar, D. M. Craig, G. Quick Jr, H. X. Jiang, M. M. Frank, A. J. Lodge, P. A.W. Anderson, and J. Jaggers Complement Factor 1 Inhibitor Improves Cardiopulmonary Function in Neonatal Cardiopulmonary Bypass Ann. Thorac. Surg., April 1, 2007; 83(4): 1477 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Stoica, M. Goddard, and S. R. Large The endothelium in clinical cardiac transplantation Ann. Thorac. Surg., March 1, 2002; 73(3): 1002 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Warnecke, B. Schulze, C. Hagl, A. Haverich, and U. Klima Improved right heart function after myocardial preservation with 2,3-butanedione 2-monoxime in a porcine model of allogenic heart transplantation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
